Development and validation of a nomogram incorporating the 31-GEP test and clinicopathologic factors for accurate prediction of recurrence risk in patients with cutaneous melanoma

Main Article Content

R Thorpe
HG Caruso
KR Covington
D Brodland
J Zitelli


GEP, cutaneous melanoma


Abstract not available.


1.Geramiet al. Clin Cancer Res. 2015 Jan 1;21(1):175-83.
2.Geramiet al. JAAD. 2015 May;72(5):780-5.e3.
3.Zager et al. BMC Cancer. 2018 Feb 5;18(1):130.
4.Gastmanet al. JAAD. 2019 Jan;80(1):149-157.e4.
5.Hsueh et al. J HematolOncol. 2017 Aug 29;10(1):152.
6.Greenhawet al. Dermatol Surg. 2018 Dec;44(12):1494-1500.
7.Keller et al. Cancer Med. 2019 May;8(5):2205-2212.